Molly Henderson - 05 Apr 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: CFO and CBO
Signature: /s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Issuer symbol: PHAT
Transactions as of: 05 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Apr 2022, 20:50:18 UTC
Previous filing: 02 Feb 2022
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Award	$0	+20,000		$0.000000	20,000	05 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHAT	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	05 Apr 2022	Common Stock	100,000	$15.08	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted on April 5, 2022. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of April 5, 2022, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2	The stock option will vest with respect to 25% of the shares of common stock on April 5, 2023, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.